19 September 2014, 10:36
The document suggests channeling 60 per cent of VAT taxation revenues from transactions on medical products and drugs supply to the State Budget for financing prevention and treatment of rare (orphan) diseases; reimbursement of costs of outpatient medicine consumption; and activity connected with bone marrow transplantation.